文献速递眼底病与葡萄膜炎

COVID-19大流行第一年原发性孔源性视网膜脱离临床特征的变化趋势

Trends in the Clinical Presentation of Primary Rhegmatogenous Retinal Detachments During the First Year of the COVID-19 Pandemic.
PubMed 文献 · Am J Ophthalmol · 2021-11-19

该单中心回顾性观察性队列研究纳入大流行队列952例和对照队列872例原发性孔源性视网膜脱离患者,比较临床特征。大流行队列黄斑受累型视网膜脱离比例(60.92%)显著高于对照队列(48.17%),最终最佳矫正视力中位数更差(0.30 logMAR vs 0.18 logMAR),失访率更高。

要点

  • 大流行队列黄斑受累型视网膜脱离比例60.92%,显著高于对照队列48.17%(P=0.0001)。
  • 大流行队列最终最佳矫正视力中位数0.30 logMAR,显著差于对照队列0.18 logMAR。
  • 大流行队列失访率10.81%,显著高于对照队列4.43%(P=0.0001)。

核心结论

  • 大流行第一年的原发性孔源性视网膜脱离患者更可能为黄斑受累型、伴有原发性增生性玻璃体视网膜病变、失访及最终最佳矫正视力结局更差。

研究设计与样本

  • 单中心回顾性观察性队列研究,大流行队列为2020年3月9日至2021年3月7日连续治疗的952例原发性孔源性视网膜脱离患者,对照队列为2019年3月11日至2020年3月8日连续治疗的872例患者。

主要发现

  • 大流行队列黄斑受累型视网膜脱离比例为60.92%,显著高于对照队列的48.17%(P=0.0001)。
  • 大流行队列原发性增生性玻璃体视网膜病变比例为15.53%,显著高于对照队列的6.9%(P=0.0001)。
  • 大流行队列失访率为10.81%,显著高于对照队列的4.43%(P=0.0001)。
  • 新就诊患者中,大流行队列黄斑受累型视网膜脱离比例为65.35%,显著高于对照队列的50.40%(P=0.0001)。
  • 大流行队列最终最佳矫正视力中位数为0.30 logMAR,显著差于对照队列的0.18 logMAR(P=0.0001)。

关键数值与推荐

  • 主要结局指标为黄斑受累型或黄斑未受累型视网膜脱离的患者比例。
  • 大流行队列黄斑受累型比例为60.92%,对照队列为48.17%(P=0.0001)。
  • 大流行队列原发性增生性玻璃体视网膜病变比例为15.53%,对照队列为6.9%(P=0.0001)。
  • 大流行队列失访率为10.81%,对照队列为4.43%(P=0.0001)。
  • 大流行队列最终最佳矫正视力中位数为0.30 logMAR,对照队列为0.18 logMAR(P=0.0001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the effect of 1 full year of the coronavirus disease 2019 (COVID-19) pandemic on clinical presentation of acute, primary rhegmatogenous retinal detachment (RRD). DESIGN: Single-center, retrospective observational cohort study. METHODS: Patients were divided into 2 cohorts: consecutive patients treated for primary RRD during the COVID-19 pandemic (March 9, 2020, to March 7, 2021; pandemic cohort) and patients treated during the corresponding time in previous year (March 11, 2019, to March 8, 2020; control cohort). MAIN OUTCOME MEASURES: Proportion of patients presenting with macula-involving (mac-off) or macula-sparring (mac-on) RRD. RESULTS: A total of 952 patients in the pandemic cohort and 872 patients in the control cohort were included. Demographic factors were similar. Compared with the control cohort, a significantly greater number of pandemic cohort patients presented with mac-off RRDs ([60.92%] pandemic, [48.17%] control, P = .0001) and primary proliferative vitreoretinopathy ([15.53%] pandemic, [6.9%] control, P = .0001). Pandemic cohort patients (10.81%) had significantly higher rates of lost to follow-up compared with the control cohort (4.43%; P = .0001). Patients new to our clinic demonstrated a significant increase in mac-off RRDs in the pandemic cohort (65.35%) compared with the control cohort (50.40%; P = .0001). Pandemic cohort patients showed worse median final best-corrected visual acuity (0.30 logarithm of the minimum angle of resolution) compared with the control cohort (0.18 logarithm of the minimum angle of resolution; P = .0001). CONCLUSIONS: Patients with primary RRD during the first year of the COVID-19 pandemic were more likely to have mac-off disease, present with primary proliferative vitreoretinopathy, be lost to follow-up, and have worse final best-corrected visual acuity outcomes.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Mundae R, Velez A, Sodhi GS, et al. Trends in the Clinical Presentation of Primary Rhegmatogenous Retinal Detachments During the First Year of the COVID-19 Pandemic. Am J Ophthalmol. 2021. PMID: 34801509. doi:10.1016/j.ajo.2021.11.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。